PDF Version
TO: Pharmacies,
Physicians, Physician Assistants, Nurse Practitioners, Oral Surgeons,
Optometrists, Dentists, FQHCs, RHCs, Mental Health Service Providers, and
Nursing Homes
Effective December 2, 2019,
the Alabama Medicaid Agency
will implement hard edits on cumulative
daily MME claims exceeding 200
MME/day. A phase-in period for claims
exceeding 150 MME/day, but less than 200 MME/day, will also be implemented.
Higher doses of opioids are associated with higher risk of overdose and
death - even relatively low dosages (20-50 MME per day) may increase risk.1
Therefore, Alabama Medicaid will limit the amount of cumulative MME allowed per
day on opioid claims. The edit began at 250 cumulative MME per day and is
gradually being decreased over time. The final cumulative MME target is
scheduled to be 90 MME per day.
Hard Edit Implementation (Greater than 200 MME):
Effective
December 2, 2019, opioid claims that exceed a cumulative MME of 200 MME/day
will be denied. The universal PA
0009996322 will no longer be valid to bypass the 200 MME edit. Pharmacy override requests for quantities
exceeding the MME limit may be submitted to Health Information Designs (HID)
and will be reviewed for medical necessity. See the link below for an override
form.
Phase-In Period (150 MME – 200 MME):
Effective
December 2, 2019, claims that exceed the cumulative daily MME limit of 150
MME/day will be denied. The dispensing pharmacist will be provided a universal prior
authorization (PA) number on the rejection screen and may enter this universal
PA number on the claim to allow it to be paid. Pharmacists are urged to notify
the affected patient/prescriber to develop a plan to decrease the patient’s
total daily MME.
Edit
Details:
· The universal PA number to override the 150
MME (but less than 200 MME) edit will
be 0009996323.
· The
universal PA number will be provided on each cumulative MME rejection screen
for the pharmacist’s convenience.
·
Additional
edits, such as therapeutic duplication, maximum quantity limitations, early
refill, non-preferred edits, etc., will still apply.
· Claims
prescribed by oncologists will bypass the edit.
· Long term care and hospice recipients are
excluded.
·
Children
are included in the edit.
· A Recipient Information Sheet for prescribers and pharmacists to provide to recipients can be found
at http://www.medicaid.alabama.gov/content/4.0_Programs/4.3_Pharmacy-DME.aspx.
1 https://www.cdc.gov/drugoverdose/prescribing/guideline.html
Anticipated Phase Down:
The
Agency plans to gradually decrease the daily cumulative MME limit every 4
months. The next decrease will be a hard edit on claims exceeding 150 MME/day
with a phase-in edit for claims that exceed 120 MME/day. This will be
implemented on April 1, 2020. Prior to each decrease, a new universal PA number
will be assigned to override claims that exceed the new threshold. Providers
will be notified via an ALERT prior to each decrease. Again, pharmacists are urged to notify the affected patient/prescriber
to develop a plan to decrease the patient’s total daily MME.
Examples of MME calculations/day include:
· 10 tablets
per day of hydrocodone/acetaminophen 5/325 = 50 MME/day
·
6
tablets per day of hydrocodone/acetaminophen 7.5/325 = 45 MME/day
· Claims
prescribed by oncologists will bypass the edit.
· 2 tablets per day of oxycodone 15 mg = 45
MME/day
· 3 tablets per day of oxycodone 10 mg = 45
MME/day
· 10 tablets per day of tramadol 50 mg = 50
MME/day
·
1
patch per 3 days of fentanyl 25mcg/hr = 60 MME/day
A
link with more information regarding MME calculations
is
https://www.cdc.gov/drugoverdose/pdf/calculating_total_daily_dose-a.pdf.
A link to the U.S. Department of Health and Human Services Guide for
Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term
Opioid Analgesics can be found at
https://medicaid.alabama.gov/documents/4.0_Programs/4.3_Pharmacy-DME/4.3_HHS_Guidance_Dosage_Reduction_Discontinuation_Opioids_10-28-19.pdf.
IMPORTANT: Only when the override is denied will the
excess quantity above the maximum unit limit be deemed a non-covered service.
Then the recipient can be charged as a cash recipient for that amount in
excess of the limit. A prescriber must not write separate
prescriptions, one to be paid by Medicaid and one to be paid as cash, to
circumvent the override process. FAILURE TO ABIDE BY MEDICAID POLICY MAY
RESULT IN RECOUPMENTS AND/OR ADMINISTRATIVE SANCTIONS. Source: Provider
Billing Manual 27.2.3
Override Requests:
Once
the hard edit is implemented, the MME Override Request Form will be used by the prescriber when requesting an override. The
form will be found at:
http://medicaid.alabama.gov/content/9.0_Resources/9.4_Forms_Library/9.4.13_Pharmacy_Forms.aspx.
Any
policy questions concerning this provider ALERT should be directed to the
Pharmacy Program at (334) 242-5050.
The Current
Procedural Terminology (CPT) and Current Dental Terminology (CDT) codes
descriptors, and other data are copyright © 2019
American Medical Association and © 2019
American Dental Association (or such other date publication of CPT and CDT).
All rights reserved. Applicable FARS/DFARS apply.